表紙:代替皮膚市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1326474

代替皮膚市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By End User, By Region and Competition

出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

代替皮膚市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

代替皮膚の世界市場は、高度な創傷ケア製品への需要の高まりとこの分野における技術進歩により、予測期間中に目覚ましい成長が見込まれています。

代替皮膚の世界市場は、医療産業の急成長分野です。代替皮膚は、患者の損傷した皮膚や欠損した皮膚の代わりとして使用され、火傷や慢性創傷、その他の皮膚損傷の治療において重要性を増しています。Joye Law Firmによると、米国では毎年約45万件の熱傷が報告されています。米国では約45,000人がホスピリティタに入院しており、そのうち約25,000人が火傷専門センターに入院しています。

代替皮膚に関する利点

代替皮膚の主な利点の一つは、創傷治癒を促進し、感染を予防することです。代替皮膚は創傷を保護するバリアとなり、さらなる損傷を防ぎ、身体が治癒に専念できるようにします。また、新しい皮膚細胞が成長するための骨組みを提供し、瘢痕の軽減にも役立ちます。代替皮膚のもうひとつの利点は、その汎用性です。代替皮膚はさまざまな医療分野で使用することができ、それぞれの患者のニーズに合わせてカスタマイズすることができます。小さな切り傷や擦り傷から大きな熱傷まで、さまざまな皮膚の損傷の治療に使用できます。さらに、代替皮膚は現代医療に欠かせないものであり、重度の皮膚損傷の治療において救命効果があることが証明されています。代替皮膚はさまざまな医療分野で使用され、それぞれの患者のニーズに合わせてカスタマイズすることができます。代替皮膚の開発は、皮膚損傷の治療に革命をもたらし、患者の予後を著しく改善しました。代替皮膚に関連するこれらすべての利点は、今後数年間における世界の代替皮膚市場の成長を促進すると予想されます。

代替皮膚における幹細胞の使用

代替皮膚の分野では近年、研究者や医療専門家がさまざまな皮膚の傷害の治療におけるこれらの製品の有効性を向上させるために、いくつかの主な発展が見られています。これらの開発は、より効果的で、より汎用性が高く、より使いやすい新製品を生み出すことを目的としており、この分野の将来において重要な役割を果たすと思われます。代替皮膚の分野における主な発展のひとつは、幹細胞の利用です。幹細胞は、体内で様々な種類の細胞に成長する能力を持つ細胞であり、損傷したり欠損したりした組織の再生を助ける可能性を持っています。研究者たちは、幹細胞を代替皮膚に使用することを研究しており、有望な結果が得られています。現在市販されている製品の中には、幹細胞を代替皮膚に組み込んだものもあり、治癒のスピードと質の向上に役立っています。

代替皮膚における3Dプリンティングの利用

3Dプリンティングは、個々の患者のニーズに合わせた複雑なカスタムデザインの代替皮膚を作ることを可能にします。この技術は、この分野に革命を起こす可能性を秘めており、より汎用性が高く使いやすい、高品質で効果的な代替皮膚の作成を容易にします。盛んな3Dプリンティング産業は、予測期間中に世界の代替皮膚市場の成長に新たな展望をもたらすと期待されています。長年にわたり、集中型3Dプリンティング施設を持つ病院の数は、2010年のわずか3件から2019年には100件に増加しました。

個別化医療の人気の高まり

代替皮膚の分野における重要な動向の1つは、個別化医療への注目の高まりです。個別化医療の人気は、ここ数年で著しく高まっています。2010年には36の医薬品が利用可能だったが、2020年にはすでに286の医薬品が利用可能になっています。様々な種類の慢性・急性創傷の治療薬として承認され、使用される個別化医療の数が増加していることから、今後数年間は世界の代替皮膚市場の成長に新たな展望が開けると予想されます。代替皮膚や創傷治療における個別化医療の関与には、年齢、性別、その他の健康状態などの要因を考慮し、患者一人ひとりのニーズに合わせて治療を調整することが含まれます。個別化医療を重視することで、研究者はより効果的で効率的な代替皮膚を生み出し、患者の転帰の改善に役立てたいと考えています。

利用可能なカスタマイズ

TechSci Researchは、所定の市場データを用いて、企業の特定のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です:

企業情報

  • 追加市場参入企業(最大5社)の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験分析

第6章 代替皮膚の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 製品マップ
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 北米の代替皮膚市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米::国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の代替皮膚市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域の代替皮膚市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の代替皮膚市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米::国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの代替皮膚市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品上市

第14章 世界の代替皮膚市場SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
    • Amarantus BioScience Holdings, Inc.
    • Organogenesis, Inc
    • Acelity L.P., Inc.
    • Smith & Nephew plc
    • BSN Medical GmbH
    • Molnlycke Health Care ABss
    • Integra LifeSciences Corporation
    • Medtronic Plc
    • Tissue Regenix Ltd.
    • Stratatech Corporation

第17章 戦略的提言

目次
Product Code: 14831

Global Skin Substitutes Market is expected to grow at an impressive rate during the forecast period on account of the increasing demand for advanced wound care products and technological advancements in the field. Global Skin Substitutes Market is a rapidly growing segment of the medical industry. Skin substitutes, which are used to replace damaged or missing skin in patients, have become increasingly important in the treatment of burns, chronic wounds, and other skin injuries. According to Joye Law Firm, around 450,000 burn injuries are reported every year in the United States. Around 45,000 people are hospitalized because of burn injuries in the United States, of which about 25,000 are admitted to specialized burn centers.

The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is one of the major factors driving the growth of the market. Additionally, the rising incidence of burns and other traumatic injuries is also contributing to the growth of the market. The annual incidence of diabetic foot ulcers worldwide is between 9.1 to 26.1 million. About 15 to 25% of patients suffering from diabetes mellitus tend to develop diabetic foot ulcers during their lifetime.

Skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. These substitutes are used to replace damaged or missing skin in patients and can be utilized in a variety of medical fields, including plastic surgery, dermatology, and burn care. Additionally, key developments in the field of skin substitutes, such as the use of advanced materials, such as nanofibers and hydrogels, and the development of new manufacturing techniques that allow for the creation of products that are more consistent and reliable. These advances are likely to lead to the creation of products that are more effective in treating a wider range of skin injuries. This, in turn, is expected to create lucrative opportunities for the growth of global skin substitutes market in the coming years.

Advantages Associated with Skin Substitutes

One of the major advantages of skin substitutes is their ability to promote wound healing and prevent infection. Skin substitutes are able to create a protective barrier over the wound, preventing further damage and allowing the body to focus on healing. They also provide a framework for new skin cells to grow and can help reduce scarring. Another advantage of skin substitutes is their versatility. Skin substitutes can be used in a variety of medical fields and can be customized to meet the needs of each patient. They can be used to treat a variety of skin injuries, from small cuts and scrapes to large burn injuries. Additionally, skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. They can be used in a variety of medical fields and can be customized to meet the needs of each patient. The development of skin substitutes has revolutionized the treatment of skin injuries and has significantly improved patient outcomes. All these advantages associated with skin substitutes are expected to drive the growth of global skin substitutes market in the coming years.

Use of Stem Cells in the Skin Substitutes

The field of skin substitutes has seen several key developments in recent years as researchers and medical professionals seek to improve the effectiveness of these products in treating a range of skin injuries. These developments are aimed at creating new products that are more effective, more versatile, and easier to use and are likely to play an important role in the future of the field. One key development in the field of skin substitutes has been the use of stem cells. Stem cells are cells that have the ability to develop into many different types of cells in the body and have the potential to help regenerate damaged or missing tissue. Researchers have been exploring the use of stem cells in skin substitutes, with promising results. Some products on the market today incorporate stem cells into the skin substitute, helping to improve the speed and quality of healing.

Use of 3D Printing in the Skin Substitutes

3D printing allows for the creation of complex, custom-designed skin substitutes that can be tailored to the needs of individual patients. This technology has the potential to revolutionize the field, making it easier to create high-quality, effective skin substitutes that are more versatile and easier to use. The flourishing 3D printing industry is expected to create new prospects for the growth of global skin substitutes market during the forecast period. Over the years, the number of hospitals with a centralized 3D printing facility increased to 100 in 2019 from just three in 2010.

Growing Popularity of Personalized Medicine

One important trend in the field of skin substitutes is the increasing focus on personalized medicine. The popularity of personalized medicine has increased significantly over the years. In 2010 there were 36 medicines available, but in 2020 there were already 286 medicines available. The increasing number of personalized medicines getting approval and gaining popularity in terms of usage for the treatment of different kinds of chronic and acute wounds is expected to open new prospects for the growth of global skin substitutes market in the next few years. The involvement of personalized medicine in skin substitutes or wound care involves tailoring treatments to the individual needs of each patient and taking into account factors such as age, gender, and other health conditions. By focusing on personalized medicine, researchers hope to create skin substitutes that are more effective and efficient and that can help improve patient outcomes.

Market Segmentation

Global Skin Substitutes Market can be segmented by type, application, end-user, and by region. Based on type, global skin substitutes market can be divided into biological and synthetic. Biological skin substitutes can be further categorized into autografts, allografts, and xenografts. In terms of application, global skin substitutes can be categorized into acute wounds and chronic wounds. Based on end users, the global skin substitutes market can be segmented into hospitals & clinics, ambulatory surgery centers, and others. Regionally, the global skin substitutes market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. United States dominated the global skin substitute market in 2022 in terms of all the countries owing to the increasing number of people getting injured in fire accidents in the United States. Around 3,500 people get fatally injured in a fire or burn accident every year in the United States, requiring the use of skin substitutes for treatment purposes, thereby driving the growth of global skin substitutes market.

Market Players

Amarantus BioScience Holdings, Inc., Organogenesis, Inc, Acelity L.P., Inc., Smith & Nephew plc, BSN Medical GmbH, Molnlycke Health Care AB, Integra LifeSciences Corporation, Medtronic Plc, Tissue Regenix Ltd., Stratatech Corporation, among others, are some of the leading players operating in the global skin substitutes market. The field of skin substitutes has seen a number of exciting new product launches in recent years as companies develop new and innovative products designed to improve the treatment of a range of skin injuries. These product launches are aimed at creating new solutions that are more effective, more versatile, and easier to use and are likely to have a major impact on the future of the global skin substitute market.

  • In November 2022, AVITA Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) had granted the company's autologous cellular therapy device for skin restoration, RECELL SYSTEM, a designation of breakthrough device. This breakthrough status will help in increasing access to RECELL SYSTEM for both patients and healthcare providers.
  • In August 2022, Organogenesis, Inc. announced that it had received U.S. Food and Drug Administration (FDA) 510k Clearance for PuraPly MZ. PuraPly MZ is based on the company's PuraPly technology, engineered into a micronized (powdered) form to provide surgeons with an option for complex surgical wounds.

Report Scope:

In this report, Global Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Skin Substitutes Market, By Type:

  • Biological
  • Autografts
  • Allografts
  • Xenografts
  • Synthetic

Skin Substitutes Market, By Application:

  • Acute Wounds
  • Chronic Wounds

Skin Substitutes Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Skin Substitutes Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Skin Substitutes Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Skin Substitute Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Biological v/s Synthetic)
      • 6.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 6.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Product Map
    • 6.3.1 By Type
    • 6.3.2 By Application
    • 6.3.3 By End User
    • 6.3.4 By Region

7. North America Skin Substitute Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Biological v/s Synthetic)
      • 7.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 7.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 7.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Skin Substitute Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Skin Substitute Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Skin Substitute Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Skin Substitute Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Biological v/s Synthetic)
      • 8.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 8.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 8.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Skin Substitute Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Skin Substitute Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Skin Substitute Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Skin Substitute Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Skin Substitute Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Skin Substitute Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Biological v/s Synthetic)
      • 9.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 9.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 9.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Skin Substitute Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Skin Substitute Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Skin Substitute Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Skin Substitute Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Skin Substitute Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Skin Substitute Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Biological v/s Synthetic)
      • 10.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 10.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 10.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Skin Substitute Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Skin Substitute Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Skin Substitute Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Skin Substitute Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Biological v/s Synthetic)
      • 11.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 11.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 11.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Skin Substitute Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Skin Substitute Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Skin Substitute Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Skin Substitute Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
    • 16.5.1. Amarantus BioScience Holdings, Inc.
    • 16.5.2. Organogenesis, Inc
    • 16.5.3. Acelity L.P., Inc.
    • 16.5.4. Smith & Nephew plc
    • 16.5.5. BSN Medical GmbH
    • 16.5.6. Molnlycke Health Care ABss
    • 16.5.7. Integra LifeSciences Corporation
    • 16.5.8. Medtronic Plc
    • 16.5.9. Tissue Regenix Ltd.
    • 16.5.10. Stratatech Corporation

17. Strategic Recommendations